Fierce Pharma

SEPTEMBER 12, 2023

The CDC wants to reset expectations for flu vaccines to correct falling uptake. | The CDC wants to reset expectations for flu vaccines to correct falling uptake. After tracking declines in vaccine use in pregnant people and children, the health body has initiated its “Wild to Mild” campaign to raise awareness of the benefits of vaccination and encourage more people to get their shots.

299

299

MedCity News

SEPTEMBER 12, 2023

U.K. doctor David Watkins has been a public critic of Babylon Health for years, during which has received anonymous emails from Babylon employees saying that the company’s AI is a sham. After Babylon collapsed, a former employee also publicly declared that the AI engine was faulty. As a longtime skeptic of Babylon’s claims surrounding its technology, Watkins said that Ali Parsa, the company’s CEO, belongs behind bars.

Doctors 140

Doctors Engineering Healthcare Healthcare 140

Fierce Pharma

SEPTEMBER 12, 2023

Eight companies are finding themselves in hot water for allegedly churning out illicit eye drugs, the FDA said Tuesday. | The companies included in the warning letter sweep are: Boiron, CVS Health, DR Vitamin Solutions, Natural Ophthalmics, OcluMed, Similasan, TRP Company and Walgreens Boots Alliance.

FDA 256

FDA 256

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. The participants were: Dr Tim Sandle, Head of GxP Compliance at Bio Products Laboratory Limited (BPL) as moderator; Dr Edward Tidswell, Executive Director within the Microbiological Quality and Sterility Assurance organisation of Merck & Co; Frederic Ayers, Research Scienti

Pharmaceutical 118

Pharmaceutical Biopharma Pharma Manufacturing 118

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

Fierce Pharma

SEPTEMBER 12, 2023

Xspray Pharma, before receiving an FDA slapdown in July, had expected to launch its competitor to Bristol Myers Squibb’s leukemia blockbuster Sprycel within the second half of 2023. | Xspray and BMS have settled patent litigation around their potential rivals Dasynoc and Sprycel, Xspray said Tuesday. The deal clears “all pending claims” and tees up a potential Dasynoc launch on Sept. 1, 2024, or potentially earlier under certain circumstances.

FDA 254

FDA Pharma 254

MedCity News

SEPTEMBER 12, 2023

Talkiatry, Array Behavioral Care, Iris Telehealth and Quartet Health sent a letter to the DEA asking for a special registration process that would allow for the prescribing of certain controlled medications via telemedicine.

Medical 110

Medical Specialization 110

Copyright Clearance Center

SEPTEMBER 12, 2023

September 12, 2023 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, today announced Gold Open Access (OA) publisher Frontiers has adopted the industry-leading Ringgold Identify Database as its Persistent Identifier (PID) solution to help power its OA models by normalizing and disambiguating organization data.

Leads 113

Leads Management Marketing 113

Fierce Pharma

SEPTEMBER 12, 2023

As Jazz Pharmaceuticals turns the page from its long-time growth driver Xyrem and leans on a trio of newer medicines for growth, its executive roster is undergoing some changes. | As Jazz turns the page from its long-time growth driver Xyrem and leans on a trio of newer medicines for growth, its executive roster is undergoing some changes.

Medicine 157

Medicine Pharmaceutical 157

Integrity Solutions

SEPTEMBER 12, 2023

As a high school football coach, I always get excited this time of year. A new team with a fresh group of kids — kids who unabashedly love the game, have a passion for getting better and strive to compete. Kids who represent their communities, fellow classmates and their families. And they’re all going after a common goal: a championship.

Sales 108

Sales Prospecting Leads Sales process 108

Medgadget

SEPTEMBER 12, 2023

Researchers at the University of Washington School of Medicine have developed a method to create stem cell-derived organoids that can produce tooth enamel proteins. The breakthrough could pave the way for lab grown enamel that can be used in dental repairs and may even allow for living fillings or completely new living teeth that can be implanted into a patient’s jaw.

Medicine 103

Medicine Patients 103

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

MedCity News

SEPTEMBER 12, 2023

As health systems shore up their defenses against cybercriminals, they should openly communicate with their third-party vendors about data security risks and work together to actively manage those risks. That was some of the advice given by Aaron Miri, Baptist Health’s chief digital and information officer, during a Tuesday webinar.

Management 102

Management Healthcare Healthcare 102

European Pharmaceutical Review

SEPTEMBER 12, 2023

The next generation of therapeutics has arrived: from simple design and development to theoretically unlimited targets, messenger RNA ( mRNA )‑based therapeutics offer a multitude of benefits. However, creating these innovative treatments harbours challenges. This article explores common developmental and design issues and how to mitigate difficulties before they occur.

Pharmaceutical 99

Pharmaceutical 99

MedCity News

SEPTEMBER 12, 2023

This on-demand webinar explores the impact of poor data quality and methods to improve patient data quality. It highlights technology that can improve workflows to help reduce workforce burnout.

Healthcare 101

Healthcare Healthcare Patients Medical 101

PM360

SEPTEMBER 12, 2023

Fishawack Health (FH) announced it is expanding its executive leadership team with the addition of Amar Urhekar as its new Chief Operating Officer (COO), a pioneer in bringing together interdisciplinary teams to solve client challenges and accelerate growth. Urhekar will play a key role on the company’s Executive Committee as he unites 1,600 employees as one team under a single vision, breaking down barriers to faster-connect patients to life-enhancing therapies.

Patients 98

Patients Healthcare Healthcare Networking 98

Advertiser: ZoomInfo

In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.

Marketing

Pharmaceutical Technology

SEPTEMBER 12, 2023

The US FDA has approved Pfizer and BioNTech’s sBLA for Omicron XBB.1.5-adapted monovalent Covid-19 vaccine, COMIRNATY 2023-2024 Formulation.

FDA 111

FDA 111

European Pharmaceutical Review

SEPTEMBER 12, 2023

A T-cell epitope cancer vaccine significantly improved overall survival in non-small cell lung cancer (NSCLC) compared to chemotherapy, Phase III data published in Annals of Oncology has shown. The immunotherapy activating tumour specific T-cells, off-the-shelf, neoepitope-based vaccine Tedopi ® was evaluated in HLA-A2 positive patients with advanced or metastatic NSCLC in monotherapy in third line NSCLC with secondary resistance to immune checkpoint inhibitors, in the Phase III clinical trial A

Patients 97

Patients Pharmaceutical Safety 97

MedCity News

SEPTEMBER 12, 2023

Avalon BioVentures unveiled new portfolio company Arialys Therapeutics. The startup’s lead program, an antibody from Astellas Pharma, is a potential treatment for anti-NMDA receptor encephalitis (ANRE), a rare autoimmune inflammatory disorder.

Pharma 97

Pharma Leads Biopharma 97

European Pharmaceutical Review

SEPTEMBER 12, 2023

Initial data from the CPHI Annual Report 2023, which provides insight from 250 global pharmaceutical companies, reveals that AI (artificial intelligence) is expected to transform every area of the industry, from drug discovery through to drug development , within the next 24-months. Data predicted that in 2030, more than half of US Food and Drug Administration (FDA)-approved drugs will involve AI in their development and/or manufacturing.

Food and Drug Administration 95

Food and Drug Administration Pharmaceutical FDA Pharma 95

Advertiser: ZoomInfo

Shifting to an account-based marketing (ABM) strategy can be both exciting and challenging. Well-implemented ABM motions build engagement with high-value accounts and drive impactful campaigns that resonate with your audience. But where do you begin, and how do you progress from crawling to running? Watch now as Demand Gen experts delve into the essentials of each stage of the ABM process.

Marketing

MedCity News

SEPTEMBER 12, 2023

Through a new partnership with Walgreens, Pearl Health will work with primary care providers by offering its technology and data insights to help them better their care and transition to value-based payment models. Walgreens is then providing prescription fulfillment, medication adherence, immunization and diagnostic testing services.

Prescription 92

Prescription Medical 92

European Pharmaceutical Review

SEPTEMBER 12, 2023

CAR T-cell therapy is a form of immunotherapy that uses specially altered T cells to fight cancer. A sample of T cells is collected from the blood of a cancer patient, genetically engineered to produce chimeric antigen receptors (CARs) on their surface, and then expanded and reinfused into the patient. These new receptors enable the cells to latch onto a specific antigen on the patient’s tumour cells and kill them.

Patients 89

Patients Pharmaceutical Specialization Engineering 89

MedCity News

SEPTEMBER 12, 2023

This new report sheds light on how the benefit consultants’ role has changed and details their perspective on the shifting employer healthcare landscape.

Consulting 98

Consulting Healthcare Healthcare 98

European Pharmaceutical Review

SEPTEMBER 12, 2023

A new state-of-the-art manufacturing facility for microbiome ecosystem therapies has now completed construction. MaaT Pharma, a company focusing on treatments for oncology, and French contract development and manufacturing organisation (CDMO) Skyepharma formed a partnership in February 2022 to build the largest current good manufacturing practice (cGMP) facility, to date, for full ecosystem microbiome therapies in Europe.

Manufacturing 89

Manufacturing Pharma Pharmaceutical Leads 89

Advertiser: ZoomInfo

One of the biggest challenges for any B2B marketer is understanding your prospects’ next move — who is most likely to buy and when. Without these insights, marketing campaigns can feel more like guesswork, with high investment and little return. We’re here to tell you there’s a better way. By tracking buyers’ digital footprints and online activity, such as website visits, product reviews, and spikes in content consumption, you can engage prospects with a message that really resonates.

Marketing

MedCity News

SEPTEMBER 12, 2023

If we want to support people with obesity, the weight loss debate must stop conflating obesity prevention with obesity treatment. Instead, we should focus on the tools that best solve the needs of people where they are – just as we would for cancer or diabetes – by making the most effective treatments possible available.

Biopharma 89

Biopharma 89

Medgadget

SEPTEMBER 12, 2023

Researchers at Stanford University have developed a new type of cancer therapy. The technology targets mucins, sugar-coated proteins that help cancer cells to metastasize and avoid the immune system. In particular, mucins enable cancer cells to survive free-floating as they travel through the blood during metastasis and can also trick immune cells into assuming that the cancer cell is not a threat.

Patients 88

Patients Medicine 88

Pharmaceutical Technology

SEPTEMBER 12, 2023

BioLineRx has received the US Food and Drug Administration approval for Aphexda plus filgrastim to mobilise haematopoietic stem cells.

Food and Drug Administration 96

Food and Drug Administration FDA Food 96

Medgadget

SEPTEMBER 12, 2023

Researchers at the University of Edinburgh have developed a new method to create multilayered tubes from cells. The technique could be very useful for recreating multilayered tubular constructs that are found in the body, such as the intestines and blood vessels. Accurately modeling such complex structures in the lab could open new doors in terms of medical research and may even pave the way for bioengineered intestinal or vascular constructs that are suitable for implantation in human patients.

Medical 80

Medical Medicine Engineering Patients 80

Advertiser: ZoomInfo

In this eBook, we’ll run through real-world examples that show how RevOps teams can benefit from modern solutions for the access, management, and activation of their GTM data. Whether you need to improve lead response times, boost adoption of core tools, improve lead qualification, or target and automate your GTM motions, you’ll find examples of how revenue teams are solving some of the toughest problems in modern business.

Leads

Pharmaceutical Technology

SEPTEMBER 12, 2023

CancerVAX plans to adapt its universal cancer vaccine platform to develop a universal CAR-T cell platform.

105

105

European Pharmaceutical Review

SEPTEMBER 12, 2023

In this exclusive interview, industry experts Laure Pomares Voisin, Quality Director, Catalent Biologics and Tony Cundell Principal Consultant, Microbiological Consulting, share critical insights into the rapidly evolving landscape of pharmaceutical environmental monitoring and microbiology. They discuss the current challenges in rapid detection, adherence to newly revised EU Good Manufacturing Practice (GMP)Annex 1 guidelines, and the importance of robust personnel training.

Pharmaceutical 77

Pharmaceutical Consulting Manufacturing Training 77

PharmaTimes

SEPTEMBER 12, 2023

The research will aim to reveal the mechanism of action of a drug target candidate - News - PharmaTimes

Pharma 92

Pharma 92

Contrarian Sales Techniques

SEPTEMBER 12, 2023

A Universal Sentiment Ever found yourself excitedly making a purchase and then, moments later, felt like you were duped by a sales pitch? You're not alone. It's a curious quirk of human nature — we all love the thrill of acquiring something new, but there's an innate aversion to feeling like we've been 'sold to'. Over the years, I've pondered this dichotomy, and it's clear that the secret to great selling lies in understanding this sentiment.

Sales pitches 64

Sales pitches Sales Product Knowledge Sales Strategy 64

Advertiser: ZoomInfo

Consolidating your tech stack is an effective cost-saving measure that drives GTM efficiency and adds value to your enterprise. With a cohesive, integrated tech stack, your revenue teams can deliver an excellent customer experience that sets you up to win faster than your competitors.